A Usability Study of a Multi-channel ECG Monitoring Device

Part of paid clinical trials in New London, North Carolina.

Sponsor
Wearlinq
Study ID
NCT07388355
Status
Recruiting
Apply to this trial

Conditions

  • Arrythmia
  • Cardiac
  • Healthy Adult Participants
  • Heart Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • eWave Patch — DEVICE
    This device is a wearable multi-channel ECG monitoring device for continuous cardiac rhythm tracking.

Study Details

This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.

Key Dates

First listed
Feb 5, 2026
Start date
Jul 6, 2026
Status verified
Jul 2026
Primary completion
Jul 31, 2027
Completion
Jul 31, 2027

Study Design

Enrollment
500 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: 7 Day Study
    Participants will receive and apply the WearLinq patch for 7 consecutive days
  • Experimental: Extended Use Cohort
    Participants will receive and apply the WearLinq patch for 30 consecutive days

Primary Outcome Measure

Wear Duration [ Time Frame: 7 Days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
ABio Clinical Research PartnersNew LondonNorth Carolina28127
Andrea Brown, MS
[email protected]
408-881-2611

Find similar trials in New London, NC

By research site
ABio Clinical Research Partners· New London, NC

Related Studies